NM_000162.5:c.1324G>T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000162.5(GCK):c.1324G>T(p.Glu442*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000162.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1459700Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726160
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
DNA sequence analysis of the GCK gene demonstrated a sequence change, c.1324G>T, which results in the creation of a premature stop codon at amino acid position 442, p.Glu442*. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated GCK protein with potentially abnormal function. This sequence change is absent from large population databases such as ExAC and gnomAD. This pathogenic sequence change has previously been described in a patient with maturity-onset diabetes of the young (MODY) (PMID: 20337973). These collective evidences indicate that this sequence change is pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.